【失智症】《Unlearn》與《AbbVie》在「AAIC」報告「數位分身」應用於失智症臨床效益

 【失智症】《Unlearn》與《AbbVie》在「AAIC」報告「數位分身」應用於失智症臨床試驗的效益

 文章出處  

Businesswire 

 

 原文標題  

Unlearn Presents Studies on AI-powered Clinical Trials with AbbVie and Johnson & Johnson Innovative Medicine at the Alzheimer's Association International Conference 2024 

 

 Twitter  

https://x.com/aimedadviser/status/1818795045807702446 

 

 文章序號  

6018 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.